As Of May 13, 2014Acorda Therapeutics Inc • May 8th, 2015 • Biological products, (no disgnostic substances) • New York
We are delighted to present this letter agreement (“Agreement”), setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Chief Business Development Officer. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of May 13, 2014 (the "Effective Date").
CIVITAS THERAPEUTICS, INC. c/o ACORDA THERAPEUTICS, INC.Alkermes Agreement • May 8th, 2015 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
Reference is made to (i) the Asset Purchase and License Agreement, as amended (the “Alkermes Agreement”), dated December 27, 2010, by and between Alkermes, Inc. (“Alkermes”) and Civitas Therapeutics, Inc., formerly known as Corregidor Therapeutics, Inc. (“Civitas”) and (ii) the Sublease (the “Sublease”), dated December 27, 2010, by and between Alkermes and Civitas. Capitalized terms used but not defined herein shall have the meanings assigned to them in the Sublease.
